Clinical Trial Update: Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Symbicort single-inhaler therapy with conventional best-practice management for persistent asthma in adults; the study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Bronchial | Phase 3 | Status: TERMINATED | Results posted: 2009-11-17